卫生保健

The work of our Healthcare business can help to make a difference to millions of lives. We put our patients at the center of everything we do.

Our Healthcare business aims to change lives

有何listic approach, we design and develop medicines and intelligent devices that strive to provide ongoing care for patients beyond their treatment. This includes medications to treat conditions such as cancer or multiple sclerosis (MS). For example, we offer an injection device and disease monitoring software outside USA and Canada that allow patients with MS to self-inject their medicine and track its administration. With cancer, we are researching the use of biomarkers that can match potential treatment to individual patients.

我们的目标是在生活的各个阶段支持人们。我们帮助许多女性和夫妇实现了生孩子的梦想。作为全球生育治疗的全球市场领导者,我们对热情做了我们的工作 - 我们将进一步思考。这就是为什么我们通过推出专用的生育技术部门来补充生育药物治疗的遗产,以帮助改善实验室的治疗结果。

我们的治疗区域

一般用药

We combine our expertise in diabetes, cardiovascular diseases and thyroid disorders to provide access to healthcare solutions.

探索更多

  1. DIABETES
  2. Cardiovascular Diseases
  3. 甲状腺疾病

生育能力

With our broad portfolio of treatment options, devices and advanced fertility technologies, we aim to contribute to improved treatment outcomes that help couples fulfill the dream of parenthood.

探索更多

  1. FERTILITY

Neurology & Immunology

我们在多发性硬化症(MS)护理方面拥有20多年的经验,并仍致力于为患者的巨大未满足需求找到解决方案。

探索更多

  1. MULTIPLE SCLEROSIS
  2. MS INSIDE OUT
  3. MS INSIDE OUT DOCUMENTARY
  4. WORLD MS DAY

Oncology

In 2018, it is estimated that more than 9.5 million people died from cancer and that number is expected to increase.

探索更多

  1. Oncology

Vibrant Thoughts Blog

Science and technology are transforming how we understand disease. Discover the people behind this innovation, and the vibrant thinking that drives them to make a difference for patients.

探索更多

  1. Vibrant Thoughts Blog

Related News

查看所有新闻
  1. 新闻发布

    德国达姆施塔特默克·卡(Merck Kgaa)突出了具有潜力的新型机制...

    Merck KGaA, Darmstadt, Germany, today provided an overview of its innovative pipeline with a focus on five mid- to late-stage assets with first-in-class and/or best-in-class potential at its R&D Update Call.

    2021/11/22

  2. 新闻发布

    德国达姆施塔特的默克·卡阿(Merck Kgaa)宣布了Arpraziquantel的积极的III阶段结果...

    默克KGAA,德国达姆施塔特和小儿Praziquantel联盟今天宣布,Arpraziquantel的Pivotal III期试验,这是一种潜在的被忽视的热带的新治疗选择。

    2021/11/16

  3. 新闻发布

    德国达姆施塔特的默克KGAA宣布新部门CFO Healthcare

    Merck KGaA, Darmstadt, Germany, today announced that effective January 1, 2022, Jakob Hoppe will become Sector CFO Healthcare, reporting to Marcus Kuhnert ...

    2021/11/16

我们每天采用以患者为导向的方法,与患者和看护人合作,在整个过程中系统地纳入他们的观点,以塑造我们设计和提供医疗保健的方式。

学到更多

Our purpose. Our patients.

We are united As One for Patients to help create, improve and prolong lives.

这是我们的目的 - 我们每天做我们每天做的事情的原因。作为患者的工作,激励我们始终尽力而为,并不断改善我们的努力。

Because we understand that every single one of us, every decision and contribution we make in our work has an impact on the lives of patients and their caregivers.

我们团结起来是患者。

免责声明

本出版物旨在提供信息;n to an international audience. Not all products discussed on this page may be available in your country and local prescribing information and approved indications may differ from country to country. For local prescribing information and approved indications, please visit our local websites.

Baidu